Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Iliac Stent Market Revenue Growth On Track For A 6.4% CAGR Through 2030
The iliac stent market has demonstrated substantial expansion in recent years. It is projected to increase from $1.09 billion in 2025 to $1.17 billion in 2026, advancing at a compound annual growth rate (CAGR) of 7.2%. This historical growth is attributable to several factors, including the increasing prevalence of peripheral artery disease, an expanding aging population, the heightened adoption of endovascular procedures, the expansion of hospital-based vascular care, and enhanced diagnosis of iliac artery lesions.
The iliac stent market is projected to experience substantial expansion over the coming years, reaching $1.5 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 6.4%. This anticipated growth is driven by several factors, including a heightened demand for minimally invasive therapies, the rising occurrence of lifestyle-related vascular conditions, broader availability of interventional cardiology services, increased healthcare spending in developing nations, and an emphasis on prompt vascular intervention. Key trends anticipated during this period encompass the increasing acceptance of minimally invasive peripheral interventions, a growing preference for self-expandable iliac stents, the expanded application of drug-eluting and covered stents for intricate lesions, a move towards outpatient and day-care endovascular procedures, and the broadened use of iliac stents in treating severe and calcified lesions.
Get A Free Sample Report With In-Depth Market Insights:
Iliac Stent Market Industry Drivers: What’s Behind The Revenue Growth?
The expanding incidence of peripheral artery diseases is projected to boost the expansion of the iliac stent market in the future. Peripheral artery disease (PAD) is a circulatory ailment marked by the constriction or obstruction of arteries beyond the heart and brain. The rising occurrence of peripheral artery diseases stems from factors such as smoking, an aging demographic, high blood pressure, and diabetes. Iliac stenting provides an efficacious therapeutic choice for individuals suffering from PAD, delivering enhanced blood flow, alleviation of symptoms, and averting complications, alongside being a minimally invasive procedure with a strong success rate. As an illustration, in July 2023, data from the US-based Society For Cardiovascular Angiography And Interventions indicated that PAD impacts 8-10 million Americans annually, with projections suggesting 19 million Americans will be affected by PAD by 2050. Consequently, the growing prevalence of peripheral artery diseases propels the iliac stent market.
Iliac Stent Market Segment Landscape And Growth Outlook
The iliac stent market covered in this report is segmented –
1) By Type: Self-Expandable Stents, Balloon-Expandable Stents, Other Types
2) By Artery Lesions: Common Iliac Artery Lesions, Severe Calcified Lesions
3) By End-Users: Hospitals, Outpatient Facilities, Other End-Users
Subsegments:
1) By Self-Expandable Stents: Nitinol Self-Expandable Stents, Polymer-Coated Self-Expandable Stents
2) By Balloon-Expandable Stents: Bare-Metal Balloon-Expandable Stents, Drug-Eluting Balloon-Expandable Stents
3) By Other Types: Covered Stents, Hybrid Stents
#Iliac Stent Market Growth Trends: What’s Shaping The Future Outlook?
Leading companies within the iliac stent market are engaged in the development of groundbreaking products like iCast, aimed at enhancing patient outcomes and minimizing the likelihood of complications. The iCast-covered stent system presents an innovative solution for treating iliac artery occlusive disease, providing enhanced performance and a reduced risk of complications when contrasted with conventional bare-metal stents. For example, in October 2023, Getinge, a healthcare company based in Sweden, announced the commercial launch of the iCast-covered stent system in the USA, following its approval by the Food and Drug Administration (FDA) for the treatment of iliac arterial occlusive disease. This particular indication highlights Getinge’s dedication to supplying high-quality products and support to US clinicians and hospital systems in addressing this severe condition.
Iliac Stent Market Top Companies Driving Competitive Growth
Major companies operating in the iliac stent market are Cardinal Health Inc., Abbott Laboratories, Medtronic Plc, Becton Dickinson and Company, Boston Scientific Corporation, B. Braun Melsungen AG, Terumo Corporation, W. L. Gore & Associates Inc, C. R. Bard Inc., Getinge AB, Cook Medical LLC, Biotronik SE & Co. KG, MicroPort Scientific Corporation, Cordis Corporation, Endologix Inc., LeMaitre Vascular Inc., Alvimedica, Clearstream Technologies Ltd., Jotec GmbH, Translumina GmbH, Vascular Concepts Limited, Lombard Medical Technologies, Acandis GmbH, Gore Medical, Medizintechnik GmbH
View The Full Iliac Stent Market Report:
Iliac Stent Market Global Footprint: Which Region Leads The Market?
North America was the largest region in the iliac stent market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the iliac stent market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
